← FDA DRUG APPROVALS

FDA ANDA · ANDA086166

ISOSORBIDE DINITRATE

Sponsor: SUN PHARM INDUSTRIES

APPLICATION
ANDA086166
TYPE
ANDA
LATEST ACTION
1998-12-01
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

ISOSORBIDE DINITRATEDiscontinued
ISOSORBIDE DINITRATE 5MG · TABLET · ORAL

Approval history

1998-12-01Manufacturing (CMC) · Supplement 38AP
1992-04-03Manufacturing (CMC) · Supplement 32AP
1992-04-03Manufacturing (CMC) · Supplement 35AP
1992-03-16Labeling · Supplement 33AP
1991-12-19Labeling · Supplement 31AP
1990-07-25Labeling · Supplement 30AP
1990-03-07Labeling · Supplement 29AP
1987-03-31Manufacturing (CMC) · Supplement 27AP
1986-09-19Manufacturing (CMC) · Supplement 24AP
1986-09-19Manufacturing (CMC) · Supplement 25AP
1986-09-19Manufacturing (CMC) · Supplement 23AP
1984-07-13Manufacturing (CMC) · Supplement 19AP
1983-11-21Manufacturing (CMC) · Supplement 17AP
1982-03-02Manufacturing (CMC) · Supplement 12AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →